California lawmakers are poised to delay the state’s much-ballyhooed new law mandating in vitro fertilization insurance coverage for millions, set to take effect July 1. Gov. Gavin Newsom has asked lawmakers to push the implementation date to January 2026, leaving patients, insurers, and employers in limbo. The law, SB 729, requires state-regulated health plans offered…
Conventional wisdom holds that it takes 17 years from medical innovation to adoption in the real-world. However, with advances in information technology, perhaps adoption timelines have shortened. A paper by DiCicca et al. (2024) examines how new clinical trial evidence on breech births impact practice patterns. Specifically, they note that: Using the United States Birth…
But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards. The post From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising appeared first on…
This brief provides information about Medicare Advantage plans in 2025, including premiums, out-of-pocket limits, supplemental benefits, and prior authorization, as well as trends over time.
Ballad Health, an Appalachian company with the nation’s largest state-sanctioned hospital monopoly, may soon be required to improve its quality of care or face the possibility of being broken up. Government documents obtained by KFF Health News reveal that Tennessee officials, in closed-door negotiations, are attempting to hold the monopoly more accountable after years of…
Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration is starting to shift the balance in favor of defenders. The post The Changing Landscape of Ransomware: Why Healthcare Organizations Are Paying Less appeared first on MedCity News.
Emrelis, an antibody drug conjugate developed by AbbVie, is now FDA approved for patients whose non-small cell lung cancer overexpresses the protein c-Met. The pharma company said this ADC is its first internally developed solid tumor medicine as well as its first solid tumor FDA approval in lung cancer. The post AbbVie’s Solid Tumor Strategy…
This data note examines trends in hospital margins from 2018 through 2023 and how operating margins varied across different types of hospitals in 2023. It shows the industry overall experienced a rebound in 2023 after margins fell sharply the previous year, though some hospitals – particularly those in rural areas and those who see many…
By GABRIELLE GOLDBLATT Highly relevant, high-resolution data streams are essential to high-stakes decision making across industries. You wouldn’t expect an investment banker making deals without full market visibility or a grocery store to stock shelves without data on what’s selling and what’s not—so why are we not leaning more into data-driven approaches in healthcare? Sensor-based…
Rural Access Advancement Program designed to assist hospitals and hospital-owned skilled nursing home facilities in rural Georgia address short-term cash deficits